Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

Author:

Cahn Pedro,Kaplan Richard,Sax Paul E,Squires Kathleen,Molina Jean-Michel,Avihingsanon Anchalee,Ratanasuwan Winai,Rojas Evelyn,Rassool Mohammed,Bloch Mark,Vandekerckhove Linos,Ruane Peter,Yazdanpanah Yazdan,Katlama Christine,Xu Xia,Rodgers Anthony,East Lilly,Wenning Larissa,Rawlins Sandy,Homony Brenda,Sklar Peter,Nguyen Bach-Yen,Leavitt Randi,Teppler Hedy,Cahn PE,Cassetti I,Losso M,Bloch MT,Roth N,McMahon J,Moore RJ,Smith D,Clumeck N,Vanderkerckhove L,Vandercam B,Moutschen M,Baril J,Conway B,Smaill F,Smith GHR,Rachlis A,Walmsley SL,Perez C,Wolff M,Lasso MF,Chahin CE,Velez JD,Sussmann O,Reynes J,Katlama C,Yazdanpanah Y,Ferret S,Durant J,Duvivier C,Poizot-Martin I,Ajana F,Rockstroh JK,Faetkanheuer G,Esser S,Jaeger H,Degen O,Bickel M,Bogner J,Arasteh K,Hartl H,Stoehr A,Rojas EM,Arathoon E,Gonzalez LD,Mejia CR,Shahar E,Turner D,Levy I,Sthoeger Z,Elinav H,Gori A,Monforte A D'Arminio,Di Perri G,Lazzarin A,Rizzardini G,Antinori A,Celesia BM,Maggiolo F,Chow TS,Lee CKC,Azwa R Iskandar Shah Raja,Mustafa M,Oyanguren M,Castillo RA,Hercilla L,Echiverri C,Maltez F,da Cunha JG Saraiva,Neves I,Teofilo E,Serrao R,Nagimova F,Khaertynova I,Orlova-Morozova E,Voronin E,Sotnikov V,Yakovlev AA,Zakharova NG,Tsybakova OA,Botes ME,Mohapi L,Kaplan R,Rassool MS,Arribas JR,Gatell JM,Negredo E,Ortega E,Troya J,Berenguer J,Aguirrebengoa K,Antela A,Calmy A,Cavassini M,Rauch A,Stoeckle M,Sheng WH,Lin HH,Tsai HC,Changpradub D,Avihingsanon A,Kiertiburanakul S,Ratanasuwan W,Nelson MR,Clarke A,Ustianowski A,Winston A,Johnson MA,Asmuth DM,Cade J,Gallant JE,Ruane PJ,Kumar PN,Luque AE,Panther L,Tashima KT,Ward D,Berger DS,Dietz CA,Fichtenbaum C,Gupta S,Mullane KM,Novak RM,Sweet DE,Crofoot GE,Hagins DP,Lewis ST,McDonald CK,DeJesus E,Sloan L,Prelutsky DJ,Rondon JC,Henn S,Scarsella AJ,Morales JO,Ramirez ,Santiago L,Zorrilla CD,Saag MS,Hsiao CB

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3